Nuveen Asset Management, LLC Atea Pharmaceuticals, Inc. Transaction History
Nuveen Asset Management, LLC
- $345 Billion
- Q3 2024
A detailed history of Nuveen Asset Management, LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 291,091 shares of AVIR stock, worth $890,738. This represents 0.0% of its overall portfolio holdings.
Number of Shares
291,091
Previous 291,091
-0.0%
Holding current value
$890,738
Previous $963,000
1.25%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AVIR
# of Institutions
109Shares Held
52.4MCall Options Held
900Put Options Held
126K-
Black Rock Inc. New York, NY9.12MShares$27.9 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN6.65MShares$20.3 Million13.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.44MShares$16.7 Million0.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.85MShares$14.8 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA4.61MShares$14.1 Million1.31% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $255M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...